End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.89 EUR | -.--% | +8.31% | -.--% |
Business Summary
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
In Vitro Diagnostic - Products
95.9
%
| 0 | 7.5 % | 0 | 95.9 % | -.--% |
Licensing
4.1
%
| 0 | 0.4 % | 0 | 4.1 % | -9.09% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
North America
54.2
%
| 0 | 4.8 % | 0 | 54.2 % | -11.45% |
Europe
38.6
%
| 0 | 3.0 % | 0 | 38.6 % | -1.06% |
Asia
7.2
%
| 6 | 92.2 % | 0 | 7.2 % | -99.39% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 875,150 | 584,339 ( 66.77 %) | 0 | 66.77 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.16% | 10.82B | |
+47.54% | 3.25B | |
-32.98% | 2.11B | |
-14.15% | 2.08B | |
-25.85% | 1.48B | |
+19.31% | 1.02B | |
-2.62% | 733M | |
-31.04% | 391M | |
-43.88% | 383M |
- Stock Market
- Equities
- ECX Stock
- ECX Stock
- Company Epigenomics AG